Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Download
Flag content
0
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial
Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Show More
Authors
Toshinari Yamashita
,
Shigehira Saji
Toshimi Takano
,
Yoichi Naito
,
Michiko Tsuneizumi
,
Akiyo Yoshimura
,
Masato Takahashi
,
Junji Tsurutani
,
Tsuguo Iwatani
,
Masahiro Kitada
,
Hiroshi Tada
,
Natsuko Mori
,
Toru Higuchi
,
Tsutomu Iwasa
,
Kazuhiro Araki
,
Kei Koizumi
,
Hiroki Hasegawa
,
Yohei Uchida
,
Satoshi Morita
+17 authors
,
Norikazu Masuda
Journal
Journal of Clinical Oncology
Published
Jan 9, 2025
DOI
10.1200/jco-24-01888
Show more
Save
Tip
Document
Download
Flag content
0
Tip
Save
Document
Download
Flag content
Paper
Conversation
Grants
Reviews